Faisal M. Khan, PhD is the Corporate Vice President of AI and Analytics at Novo Nordisk. His work focuses on the intersections of AI/ML, data science, biostatistics, personalized medicine, and healthcare delivery. His career has encompassed all aspects of healthcare and biomedical data science, including diagnostics, devices, drug R&D and clinical trials, and payers/insurance. Dr. Khan has worked or consulted across academia and industry with both startups and Fortune-50 companies. He has over 100 published papers, abstracts, and patents.  Dr. Khan has been a graduate instructor in the Analytics track of the Rutgers Master of Business and Science program since 2013.